We look forward to working together while continuing to further expand our pipeline in other indications with high unmet medical need, such as bladder cancer.' Pharmanovia CEO, Dr. James Burt added: ...

Researchers have carried out an in-depth analysis of 10,478 cancer genomes across 35 different cancer types, identifying 330 ...

FAP is a pan-cancer marker expressed in the tumor microenvironment of epithelial cancers and on the surface of some specific cancer types, including sarcomas and mesotheliomas.

The SARAH trial was limited to high-risk patients, which the lead investigator said prevented unnecessary exposure to adverse ...

Donations to this year’s Leamington Rotary Club’s Leamington and Whitnash Trees of Light campaign can help to support people ...

The robot surgery can slash the risk of severe incontinence. It is designed to avoid long-term damage to the urethra - the ...

And these data are really quite interesting and impressive that if you don't progress and that your time on [enfortumab ...

Most bladder cancers start in the inside lining of the bladder. Muscle-invasive bladder cancer (MIBC) is cancer found in the ...

Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to an editorial published in ...

presented to its investors. CG Oncology, Inc. is a late-stage clinical biopharmaceutical company dedicated to developing bladder-sparing therapies for bladder cancer patients, with a focus on ...